Oragenics (AMEX:OGEN) is set to give its latest quarterly earnings report on Wednesday, 2022-04-27. Here's what investors need to know before the announcement.
Analysts estimate that Oragenics will report an earnings per share (EPS) of $-0.02.
Oragenics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
Here's a look at Oragenics's past performance and the resulting price change:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.04 | |||
| EPS Actual | -0.02 | -0.04 | -0.03 | -0.05 |
| Price Change % | -10.46% | -4.1% | 6.89% | 1.49% |
Stock Performance
Shares of Oragenics were trading at $0.3549 as of April 25. Over the last 52-week period, shares are down 57.79%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.
To track all earnings releases for Oragenics visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
